1. Home
  2. ACHV vs SUPV Comparison

ACHV vs SUPV Comparison

Compare ACHV & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$8.18

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

HOLD

Current Price

$8.01

Market Cap

703.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
SUPV
Founded
N/A
1887
Country
United States
Argentina
Employees
N/A
3348
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
726.5M
703.9M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ACHV
SUPV
Price
$8.18
$8.01
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$14.67
$13.00
AVG Volume (30 Days)
1.4M
475.7K
Earning Date
05-11-2026
05-26-2026
Dividend Yield
N/A
2.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$86.20
Revenue Next Year
N/A
$25.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$4.54
52 Week High
$8.64
$13.55

Technical Indicators

Market Signals
Indicator
ACHV
SUPV
Relative Strength Index (RSI) 60.88 33.66
Support Level $4.03 $7.70
Resistance Level $8.63 $10.24
Average True Range (ATR) 0.37 0.30
MACD -0.01 -0.06
Stochastic Oscillator 75.46 0.79

Price Performance

Historical Comparison
ACHV
SUPV

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA a diversified financial services group in Argentina. It offers a broad range of financial products and services including lending, savings and investments, insurance, payments and cash management services, car loans, and asset management, positioning itself as a one-stop destination for financial needs. It operates exclusively in Argentina, through the Bank, which serves as its main banking subsidiary, delivering a comprehensive suite of financial services to retail, SMEs and corporate customers. Its segments include Personal & Business Banking; Corporate Banking; Bank Treasury; Insurance; and Asset Management and Other Services (which includes IOL invertironline). The majority of the revenue is derived from Personal & Business Banking segment.

Share on Social Networks: